|

VPV 500 mg Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Also known as: Vapendaivr

Pipeline

Phase 2: 1

Top Sponsors

  • Altesa Biosciences, Inc.1

Indications

  • Rhinovirus Infection1
  • COPD1

Mobile, Alabama1 trial

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Velocity Clinical Research - Mobile

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.